Resultats globals: 2 registres trobats en 0.02 segons.
Articles, 2 registres trobats
Articles 2 registres trobats  
1.
10 p, 367.0 KB ESMO Management and treatment adapted recommendations in the COVID-19 era : Lung cancer / Passaro, Antonio (IRCCS European Institute of Oncology (Milà, Itàlia)) ; Addeo, Alfredo (Geneva University Hospitals (Suïssa)) ; Von Garnier, Christophe (Centre Hospitalier Universitaire Vaudois) ; Blackhall, Fiona (University of Manchester) ; Planchard, David (Gustave Roussy) ; Felip, Enriqueta (Vall d'Hebron Institut d'Oncologia) ; Dziadziuszko, Rafal (Gdanski Uniwersytet Medyczny) ; De Marinis, Filippo (IRCCS European Institute of Oncology (Milà, Itàlia)) ; Reck, Martin (LungenClinic) ; Bouchaab, Hasna (Centre Hospitalier Universitaire Vaudois) ; Peters, Solange (Centre Hospitalier Universitaire Vaudois) ; Universitat Autònoma de Barcelona
The COVID-19 pandemic, characterised by a fast and global spread during the first months of 2020, has prompted the development of a structured set of recommendations for cancer care management, to maintain the highest possible standards. [...]
2020 - 10.1136/esmoopen-2020-000820
ESMO open, Vol. 5 (january 2020)  
2.
6 p, 263.8 KB A multicentre phase II gene expression profiling study of putative relationships between tumour biomarkers and clinical response with erlotinib in non-small-cell lung cancer / Tan, E. H. (National Cancer Centre (Singapur). Department of Medical Oncology) ; Ramlau, Rodryg (Regional Lung Disease Centre (Poznan). Department of Oncology) ; Pluzanska, A. (Regional Oncology Centre (Lodz, Polònia). Oncological Chemotherapy Clinic) ; Kuo, H. -P. (Chang Gung Memorial Hospital (Linkou, Taiwan). Department of Thoracic Medicine) ; Reck, Martin (Hospital Grosshansdorf (Grosshansdorf, Alemanya). Department of Thoracic Oncology) ; Milanowski, J. (Akademia Medyczna w Lublinie (Lublin, Polònia). Department of Pneumology, Oncology and Allergology) ; Au, J. S. -K. (Queen Elizabeth Hospital (Hong Kong). Department of Clinical Oncology) ; Felip, Enriqueta (Hospital Universitari Vall d'Hebron) ; Yang, P. -C. (National Taiwan University Hospital (Taipei, Taiwan)) ; Damyanov, D. (Specialized Hospital for Active Treatment in Oncology (Sofia, Bulgaria)) ; Orlov, S. (Pavlov State Medical University. Research Institute of Pulmonology (Sant Petersburg, Rússia)) ; Akimov, Mikhail (Hoffmann-La Roche (Basel, Suïssa)) ; Delmar, P. (Hoffmann-La Roche (Basel, Suïssa)) ; Essioux, L. (Hoffmann-La Roche (Basel, Suïssa)) ; Hillenbach, C. (Hoffmann-La Roche (Basel, Suïssa)) ; Klughammer, B. (Hoffmann-La Roche (Basel, Suïssa)) ; McLoughlin, P. (Hoffmann-La Roche (Basel, Suïssa)) ; Baselga Torres, Josep, 1959-2021, (Hospital Universitari Vall d'Hebron)
Background: Identification of appropriate markers for predicting clinical benefit with erlotinib in non-small-cell lung cancer (NSCLC) may be able to guide patient selection for treatment. This open-label, multicentre, phase II trial aimed to identify genes with potential use as biomarkers for clinical benefit from erlotinib therapy. [...]
2010
Annals of oncology, Vol. 21, Issue 2 (2010) , p. 217-222  

Vegeu també: autors amb noms similars
2 Reck, Martin
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.